Ethyleugenol

Ethyleugenol

SCHEMBL357018

C=CCc1ccc(OCC)c(OC)c1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.77
PPARA Q07869 3/20 0.77
PPARG P37231 1/20 0.77
PPARD Q03181 1/20 0.77
MAPT P10636 6/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
KDM4E B2RXH2 2/20 0.68
LMNA P02545 2/20 0.68
GAA P10253 2/20 0.68
HTT P42858 1/20 0.68
NPC1 O15118 4/20 0.67
RAB9A P51151 3/20 0.67
TP53 P04637 1/20 0.67
TSHR P16473 1/20 0.67
PTGS1 P23219 2/20 0.61
CYP3A4 P08684 2/20 0.61
ALOX5 P09917 1/20 0.61
AR P10275 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyleugenol SCHEMBL3625384 0.95 ALDH1A1 (0.71) ALDH1A1PPARAPPARGPPARDMAPT
SCHEMBL10536910 0.88 ALDH1A1 (0.80) ALDH1A1PPARAPPARGPPARDMAPT
Methyleugenol SCHEMBL1869396 0.88 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDMAPT
Methyleugenol SCHEMBL29376951 0.88 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDMAPT
Methyleugenol SCHEMBL113794 0.88 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDMAPT
Propyleugenol SCHEMBL15086517 0.87 ALDH1A1 (0.73) ALDH1A1PPARAPPARGPPARDMAPT
SCHEMBL9721996 0.87 ALDH1A1 (0.77) ALDH1A1PPARAPPARGPPARDMAPT
SCHEMBL2092430 0.87 ALDH1A1 (0.77) ALDH1A1PPARAPPARGPPARDMAPT
Allyleugenol SCHEMBL2779960 0.87 ALDH1A1 (0.77) ALDH1A1PPARAPPARGPPARDMAPT
SCHEMBL2094711 0.87 ALDH1A1 (0.57) ALDH1A1PPARAPPARGPPARDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107573073-B Graphite product and preparation method thereof 佛山市巴伦亚合金材料科技有限公司 2019-09-10 CN claimed
CN-107573073-A Graphite product and preparation method thereof 佛山市巴伦亚合金材料科技有限公司 2018-01-12 CN claimed
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar SIMON FRASER UNIVERSITY (CA) 2013-02-21 US claimed
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR SIMON FRASER UNIVERSITY (CA) 2010-11-25 US claimed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US claimed
EP-1767514-B1 Process for the isomerisation of alkenylalkoxybenzenen SYMRISE GMBH & CO KG (DE) 2010-03-31 EP claimed
US-20070073089-A1 Process for the Isomerisation of Alkenyl Alkoxybenzenes SYMRISE GMBH & CO. KG (DE) 2007-03-29 US claimed
JP-9249549-A None JP disclosed
JP-9241116-A None JP disclosed
JP-6287135-A None JP disclosed
CN-115103719-B Encapsulated fragrance based on natural amino acids 西姆莱斯股份公司 2024-12-06 CN disclosed
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound SHIKOKU CHEMICALS CORPORATION (JP) 2023-10-03 US disclosed
CN-113801022-B Eugenol ferulate and isoeugenol hybrid and application thereof 贵州大学 2023-07-28 CN disclosed
CN-1324380-A Gel composition PENRECO (US) 2001-11-28 CN disclosed
EP-1141111-A1 GEL COMPOSITIONS Penreco (US) 2001-10-10 EP disclosed
WO-2000026285-A1 GEL COMPOSITIONS PENRECO (US) 2000-05-11 WO disclosed
JP-H09249549-A COSMETIC COMPOSITION LION CORP 1997-09-22 JP disclosed
JP-H09241116-A COSMETIC COMPOSITION LION CORP 1997-09-16 JP disclosed
JP-H06287135-A EXTERNAL AGENT COMPOSITION FOR SKIN LION CORP 1994-10-11 JP disclosed
US-4154769-A Process for the production of 2-alkoxy-4-propen-1-yl-phenols HAARMANN & REIMER GMBH (DE) 1979-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar L3MBTL3, L3MBTL4, L3MBTL1 ALDH1A1 4074/4885PPARA 3865/4885PPARG 4433/4885
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 ALDH1A1 4132/4885PPARA 3859/4885PPARG 4431/4885
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound TST, TMT1A, CTH ALDH1A1 412/4885PPARA 2335/4885PPARG 3710/4885
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR L3MBTL3, L3MBTL4, L3MBTL1 ALDH1A1 4180/4885PPARA 3912/4885PPARG 4457/4885
US-20070073089-A1 Process for the Isomerisation of Alkenyl Alkoxybenzenes ADH1C, ADH1A, AKR7A2 ALDH1A1 53/4885PPARA 3874/4885PPARG 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.